San Diego, CA 7/2/2009 3:03:10 AM
Poniard Pharmaceuticals (PARD) Rallies on Cancer Treatment - Analysis at Small Cap Network
Poniard Pharmaceuticals, Inc. (PARD)
Poniard Pharmaceuticals, Inc. (PARD) has hit new 52-week highs today, largely propelled by recent news regarding its Phase III trial of Picoplatin for the treatment of small cell lung cancer. A brief review is available at the Small Cap Network.
Small cap and biotech investors who want to review an analysis of Poniard and related companies as well as receive exclusive stock picks and market analysis can subscribe to the site's newsletter by visiting: http://www.smallcapnetwork.com/t/About Poniard Pharmaceuticals
Poniard Pharmaceuticals (PARD) is a specialty pharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer. Poniard Pharmaceuticals is currently conducting clinical trials to evaluate picoplatin in patients with small cell lung cancer, colorectal cancer and hormone-refractory prostate cancer. In addition, preclinical studies are underway to assess the application of picoplatin in an oral formulation. The company's development efforts are focused on picoplatin, a new generation platinum therapy that provides a differentiated spectrum of activity and an improved safety profile. An intravenous chemotherapeutic agent, picoplatin is designed to overcome platinum resistance associated with the treatment of solid tumors. .
About Us
The comments and outlooks offered by Small Cap Network's research staff combine technical and fundamental approaches that not only find the attractive stocks. but also determine the ideal times to buy or sell them. The organization's broad market-based calls draw on decades worth of investing experience, and an effective combination of breadth and depth tools.
The website, which emphasizes small cap stock trading, posts its individual stock picks and market calls daily on its website. Highlights of those commentaries are e-mailed to subscribers through a complimentary newsletter. To register for the newsletter or learn more about today's focus stocks, investors can go to: www.smallcapnetwork.com/t/.
The website and its interactive community pages are becoming one of the web's preferred destinations for active investors searching for unbiased small cap and micro cap commentary. The free newsletter provides the site's highlights for those who receive it, while the blog and community pages provide an enormous amount of exclusive commentary on the undercovered small cap segment of the equity market.
Forward-Looking Statement:
This press release may include or imply "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
SmallCapNetwork.com is not a registered investment adviser or broker/dealer. SmallCapNetwork.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for many of their securities, investing in such securities is highly speculative and carries a high degree of risk.
Contact Information:
Small Cap Network
4653 Carmel Mtn. Rd
Suite 308 #402
San Diego, CA 92130
Email: editor@smallcapnetwork.com
Source: Small Cap Network
